{'fraction_non_alphanumeric': 0.04421768707482993, 'fraction_numerical': 0.04251700680272109, 'mean_word_length': 5.130208333333333, 'pattern_counts': {'":': 0, '<': 3, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Expression Profile of Long Non Coding RNA PVT1 in Patients with Ulcerative Colitis

Background: Ulcerative colitis (UC) is a chronic progressive inflammatory bowel
disease, many long non coding RNA (lncRNAs) have been studied to have a role in the
pathogenesis of Ulcerative colitis. Objective: is to evaluate expression level of long
noncoding RNA PVT1 in ulcerative colitis and its association with the severity of the
disease. Methodology: Sixty ulcerative colitis patients and 60 subjects were enrolled as
controls. LNCRNA PVT1 relative expression level was tested using miScript SYBR Green
PCR Kit. Results: Results showed significant differences between the patients with
ulcerative colitis and controls as regard the median of the relative expression level of
LNC PVT1 (P<0.0001). Also, there were positive significant correlations between the
expression level of LNC PVT1 and AST(r=0.398, p=0.002), WBC(r=0.473, p<0.0001) in
UC patients. The ROC curve analysis of LNC PVT1 revealed; LNC PVT1; AUC=0.784,
P<0.0001, cut off point 1.06, sensitivity 73.3%, specificity 83.3%. Conclusion: Serum
Lnc PVT1 could be used as a potential biomarker for UC diagnosis and prognosis